Click for best price
Antiemetic Drugs Market Size, Share 2024
This research report provides a comprehensive analysis of the Antiemetic Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Antiemetic Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Antiemetic Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Antiemetic Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Antiemetic Drugs market presents opportunities for various stakeholders, including Chemotherapy, Gastroenteritis. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Antiemetic Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Antiemetic Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.
Key Features:
The research report on the Antiemetic Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Antiemetic Drugs market.
Market Overview: The report provides a comprehensive overview of the Antiemetic Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Dopamine Antagonist, 5-HT-3 Receptor Antagonist), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Antiemetic Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Antiemetic Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Antiemetic Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Antiemetic Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Antiemetic Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Antiemetic Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Antiemetic Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Antiemetic Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Antiemetic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Market segment by Application
Chemotherapy
Gastroenteritis
Surgery
Global Antiemetic Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiemetic Drugs, market overview.
Chapter 2: Global Antiemetic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Antiemetic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiemetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antiemetic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antiemetic Drugs Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
137 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiemetic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiemetic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiemetic Drugs Overall Market Size
2.1 Global Antiemetic Drugs Market Size: 2023 VS 2030
2.2 Global Antiemetic Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Antiemetic Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Antiemetic Drugs Players in Global Market
3.2 Top Global Antiemetic Drugs Companies Ranked by Revenue
3.3 Global Antiemetic Drugs Revenue by Companies
3.4 Global Antiemetic Drugs Sales by Companies
3.5 Global Antiemetic Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Antiemetic Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Antiemetic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiemetic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Antiemetic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Antiemetic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiemetic Drugs Market Size Markets, 2023 & 2030
4.1.2 Dopamine Antagonist
4.1.3 5-HT-3 Receptor Antagonist
4.1.4 NK1 Receptor Antagonist
4.1.5 Cannabinoid Receptor Antagonist
4.2 By Type - Global Antiemetic Drugs Revenue & Forecasts
4.2.1 By Type - Global Antiemetic Drugs Revenue, 2019-2024
4.2.2 By Type - Global Antiemetic Drugs Revenue, 2025-2030
4.2.3 By Type - Global Antiemetic Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Antiemetic Drugs Sales & Forecasts
4.3.1 By Type - Global Antiemetic Drugs Sales, 2019-2024
4.3.2 By Type - Global Antiemetic Drugs Sales, 2025-2030
4.3.3 By Type - Global Antiemetic Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Antiemetic Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiemetic Drugs Market Size, 2023 & 2030
5.1.2 Chemotherapy
5.1.3 Gastroenteritis
5.1.4 Surgery
5.2 By Application - Global Antiemetic Drugs Revenue & Forecasts
5.2.1 By Application - Global Antiemetic Drugs Revenue, 2019-2024
5.2.2 By Application - Global Antiemetic Drugs Revenue, 2025-2030
5.2.3 By Application - Global Antiemetic Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Antiemetic Drugs Sales & Forecasts
5.3.1 By Application - Global Antiemetic Drugs Sales, 2019-2024
5.3.2 By Application - Global Antiemetic Drugs Sales, 2025-2030
5.3.3 By Application - Global Antiemetic Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Antiemetic Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Antiemetic Drugs Market Size, 2023 & 2030
6.2 By Region - Global Antiemetic Drugs Revenue & Forecasts
6.2.1 By Region - Global Antiemetic Drugs Revenue, 2019-2024
6.2.2 By Region - Global Antiemetic Drugs Revenue, 2025-2030
6.2.3 By Region - Global Antiemetic Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Antiemetic Drugs Sales & Forecasts
6.3.1 By Region - Global Antiemetic Drugs Sales, 2019-2024
6.3.2 By Region - Global Antiemetic Drugs Sales, 2025-2030
6.3.3 By Region - Global Antiemetic Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Antiemetic Drugs Revenue, 2019-2030
6.4.2 By Country - North America Antiemetic Drugs Sales, 2019-2030
6.4.3 US Antiemetic Drugs Market Size, 2019-2030
6.4.4 Canada Antiemetic Drugs Market Size, 2019-2030
6.4.5 Mexico Antiemetic Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Antiemetic Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Antiemetic Drugs Sales, 2019-2030
6.5.3 Germany Antiemetic Drugs Market Size, 2019-2030
6.5.4 France Antiemetic Drugs Market Size, 2019-2030
6.5.5 U.K. Antiemetic Drugs Market Size, 2019-2030
6.5.6 Italy Antiemetic Drugs Market Size, 2019-2030
6.5.7 Russia Antiemetic Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Antiemetic Drugs Market Size, 2019-2030
6.5.9 Benelux Antiemetic Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Antiemetic Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Antiemetic Drugs Sales, 2019-2030
6.6.3 China Antiemetic Drugs Market Size, 2019-2030
6.6.4 Japan Antiemetic Drugs Market Size, 2019-2030
6.6.5 South Korea Antiemetic Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Antiemetic Drugs Market Size, 2019-2030
6.6.7 India Antiemetic Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Antiemetic Drugs Revenue, 2019-2030
6.7.2 By Country - South America Antiemetic Drugs Sales, 2019-2030
6.7.3 Brazil Antiemetic Drugs Market Size, 2019-2030
6.7.4 Argentina Antiemetic Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antiemetic Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Antiemetic Drugs Sales, 2019-2030
6.8.3 Turkey Antiemetic Drugs Market Size, 2019-2030
6.8.4 Israel Antiemetic Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Antiemetic Drugs Market Size, 2019-2030
6.8.6 UAE Antiemetic Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Antiemetic Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Antiemetic Drugs Major Product Offerings
7.2.4 Johnson & Johnson Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Antiemetic Drugs Major Product Offerings
7.3.4 Pfizer Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Pfizer Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Antiemetic Drugs Major Product Offerings
7.4.4 Sanofi Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Sanofi Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Antiemetic Drugs Major Product Offerings
7.5.4 Abbott Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Abbott Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Antiemetic Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Antiemetic Drugs Major Product Offerings
7.7.4 Cipla Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Cipla Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Antiemetic Drugs Major Product Offerings
7.8.4 Eisai Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Eisai Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Antiemetic Drugs Major Product Offerings
7.9.4 Eli Lilly Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Glenmark
7.10.1 Glenmark Company Summary
7.10.2 Glenmark Business Overview
7.10.3 Glenmark Antiemetic Drugs Major Product Offerings
7.10.4 Glenmark Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Glenmark Key News & Latest Developments
7.11 Helsinn Healthcare
7.11.1 Helsinn Healthcare Company Summary
7.11.2 Helsinn Healthcare Business Overview
7.11.3 Helsinn Healthcare Antiemetic Drugs Major Product Offerings
7.11.4 Helsinn Healthcare Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Helsinn Healthcare Key News & Latest Developments
7.12 Heron Therapeutics
7.12.1 Heron Therapeutics Company Summary
7.12.2 Heron Therapeutics Business Overview
7.12.3 Heron Therapeutics Antiemetic Drugs Major Product Offerings
7.12.4 Heron Therapeutics Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Heron Therapeutics Key News & Latest Developments
7.13 IPCA Laboratories
7.13.1 IPCA Laboratories Company Summary
7.13.2 IPCA Laboratories Business Overview
7.13.3 IPCA Laboratories Antiemetic Drugs Major Product Offerings
7.13.4 IPCA Laboratories Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.13.5 IPCA Laboratories Key News & Latest Developments
7.14 Lupin
7.14.1 Lupin Company Summary
7.14.2 Lupin Business Overview
7.14.3 Lupin Antiemetic Drugs Major Product Offerings
7.14.4 Lupin Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Lupin Key News & Latest Developments
7.15 Merck
7.15.1 Merck Company Summary
7.15.2 Merck Business Overview
7.15.3 Merck Antiemetic Drugs Major Product Offerings
7.15.4 Merck Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Merck Key News & Latest Developments
7.16 Novartis
7.16.1 Novartis Company Summary
7.16.2 Novartis Business Overview
7.16.3 Novartis Antiemetic Drugs Major Product Offerings
7.16.4 Novartis Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.16.5 Novartis Key News & Latest Developments
7.17 RedHill
7.17.1 RedHill Company Summary
7.17.2 RedHill Business Overview
7.17.3 RedHill Antiemetic Drugs Major Product Offerings
7.17.4 RedHill Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.17.5 RedHill Key News & Latest Developments
7.18 Sun Pharmaceutical Industries
7.18.1 Sun Pharmaceutical Industries Company Summary
7.18.2 Sun Pharmaceutical Industries Business Overview
7.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Major Product Offerings
7.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.18.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.19 Takeda Pharmaceutical
7.19.1 Takeda Pharmaceutical Company Summary
7.19.2 Takeda Pharmaceutical Business Overview
7.19.3 Takeda Pharmaceutical Antiemetic Drugs Major Product Offerings
7.19.4 Takeda Pharmaceutical Antiemetic Drugs Sales and Revenue in Global (2019-2024)
7.19.5 Takeda Pharmaceutical Key News & Latest Developments
8 Global Antiemetic Drugs Production Capacity, Analysis
8.1 Global Antiemetic Drugs Production Capacity, 2019-2030
8.2 Antiemetic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Antiemetic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antiemetic Drugs Supply Chain Analysis
10.1 Antiemetic Drugs Industry Value Chain
10.2 Antiemetic Drugs Upstream Market
10.3 Antiemetic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antiemetic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Antiemetic Drugs in Global Market
Table 2. Top Antiemetic Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Antiemetic Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Antiemetic Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Antiemetic Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Antiemetic Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Antiemetic Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Antiemetic Drugs Product Type
Table 9. List of Global Tier 1 Antiemetic Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiemetic Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Antiemetic Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Antiemetic Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Antiemetic Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Antiemetic Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Antiemetic Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Antiemetic Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Antiemetic Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Antiemetic Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Antiemetic Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Antiemetic Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Antiemetic Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Antiemetic Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Antiemetic Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Antiemetic Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Antiemetic Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Antiemetic Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Antiemetic Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Antiemetic Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Antiemetic Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Antiemetic Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Antiemetic Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Antiemetic Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Antiemetic Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Antiemetic Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Antiemetic Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Antiemetic Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Antiemetic Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Antiemetic Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Antiemetic Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Antiemetic Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Antiemetic Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Antiemetic Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Antiemetic Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Antiemetic Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Antiemetic Drugs Sales, (K Units), 2025-2030
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Antiemetic Drugs Product Offerings
Table 48. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Antiemetic Drugs Product Offerings
Table 52. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Antiemetic Drugs Product Offerings
Table 56. Pfizer Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Antiemetic Drugs Product Offerings
Table 60. Sanofi Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Sanofi Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Antiemetic Drugs Product Offerings
Table 64. Abbott Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Abbott Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Antiemetic Drugs Product Offerings
Table 68. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Cipla Company Summary
Table 71. Cipla Antiemetic Drugs Product Offerings
Table 72. Cipla Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Cipla Key News & Latest Developments
Table 74. Eisai Company Summary
Table 75. Eisai Antiemetic Drugs Product Offerings
Table 76. Eisai Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Eisai Key News & Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Antiemetic Drugs Product Offerings
Table 80. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Eli Lilly Key News & Latest Developments
Table 82. Glenmark Company Summary
Table 83. Glenmark Antiemetic Drugs Product Offerings
Table 84. Glenmark Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Glenmark Key News & Latest Developments
Table 86. Helsinn Healthcare Company Summary
Table 87. Helsinn Healthcare Antiemetic Drugs Product Offerings
Table 88. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Helsinn Healthcare Key News & Latest Developments
Table 90. Heron Therapeutics Company Summary
Table 91. Heron Therapeutics Antiemetic Drugs Product Offerings
Table 92. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. Heron Therapeutics Key News & Latest Developments
Table 94. IPCA Laboratories Company Summary
Table 95. IPCA Laboratories Antiemetic Drugs Product Offerings
Table 96. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. IPCA Laboratories Key News & Latest Developments
Table 98. Lupin Company Summary
Table 99. Lupin Antiemetic Drugs Product Offerings
Table 100. Lupin Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 101. Lupin Key News & Latest Developments
Table 102. Merck Company Summary
Table 103. Merck Antiemetic Drugs Product Offerings
Table 104. Merck Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 105. Merck Key News & Latest Developments
Table 106. Novartis Company Summary
Table 107. Novartis Antiemetic Drugs Product Offerings
Table 108. Novartis Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 109. Novartis Key News & Latest Developments
Table 110. RedHill Company Summary
Table 111. RedHill Antiemetic Drugs Product Offerings
Table 112. RedHill Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 113. RedHill Key News & Latest Developments
Table 114. Sun Pharmaceutical Industries Company Summary
Table 115. Sun Pharmaceutical Industries Antiemetic Drugs Product Offerings
Table 116. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 117. Sun Pharmaceutical Industries Key News & Latest Developments
Table 118. Takeda Pharmaceutical Company Summary
Table 119. Takeda Pharmaceutical Antiemetic Drugs Product Offerings
Table 120. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 121. Takeda Pharmaceutical Key News & Latest Developments
Table 122. Antiemetic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 123. Global Antiemetic Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 124. Global Antiemetic Drugs Production by Region, 2019-2024 (K Units)
Table 125. Global Antiemetic Drugs Production by Region, 2025-2030 (K Units)
Table 126. Antiemetic Drugs Market Opportunities & Trends in Global Market
Table 127. Antiemetic Drugs Market Drivers in Global Market
Table 128. Antiemetic Drugs Market Restraints in Global Market
Table 129. Antiemetic Drugs Raw Materials
Table 130. Antiemetic Drugs Raw Materials Suppliers in Global Market
Table 131. Typical Antiemetic Drugs Downstream
Table 132. Antiemetic Drugs Downstream Clients in Global Market
Table 133. Antiemetic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antiemetic Drugs Segment by Type in 2023
Figure 2. Antiemetic Drugs Segment by Application in 2023
Figure 3. Global Antiemetic Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Antiemetic Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Antiemetic Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Antiemetic Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antiemetic Drugs Revenue in 2023
Figure 9. By Type - Global Antiemetic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Antiemetic Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Antiemetic Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Antiemetic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Antiemetic Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Antiemetic Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Antiemetic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Antiemetic Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Antiemetic Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Antiemetic Drugs Sales Market Share, 2019-2030
Figure 23. US Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Antiemetic Drugs Sales Market Share, 2019-2030
Figure 28. Germany Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Antiemetic Drugs Sales Market Share, 2019-2030
Figure 37. China Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Antiemetic Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Antiemetic Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Antiemetic Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Antiemetic Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Antiemetic Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Antiemetic Drugs by Region, 2023 VS 2030
Figure 54. Antiemetic Drugs Industry Value Chain
Figure 55. Marketing Channels
